“This meeting is a ‘Who’s Who’ of physicians who treat valvular heart disease from around the world,” said Program Director David H. Adams, MD, Professor and Chair of Cardiothoracic Surgery at The Mount Sinai Medical Center. “AATS is the premiere association for thoracic surgeons, and experts from all of the top heart valve centers in the world will be presenting.”
Speakers will discuss the latest information in mitral valve repair and disease, including management guidelines, imaging, pathology, minimally invasive and percutaneous approaches, surgical techniques, devices, and long-term results. Faculty presentations of the latest available data, techniques, and state-of-the-art reviews will be supplemented by abstracts and video presentations selected by the program committee from submitted original work.
Highlights will include presentations of new research by Dr. Adams and his team, such as data showing a near 100 percent repair rate in degenerative mitral valve disease in 775 consecutive patients treated at Mount Sinai from January 2002 to December 2010. The conclusion will show that a systematic strategy of mitral valve repair that includes both resectional and non-resectional approaches allows repair of all degenerative valves, with good short-term outcomes and mid-term durability.
Dr. Adams and his team will also present early results from patients with degenerative mitral valve disease who were treated with the new Medtronic Tri-Ad™ Adams Tricuspid Annuloplasty Ring, that was invented by Dr. Adams at Mount Sinai and is the first tricuspid annuloplasty ring to treat functional tricuspid valve disease.
Additionally, Dr. Adams will present the Mitral Conclave Achievement award to the renowned French cardiac surgeon, Alain Carpentier, MD, who is also an Adjunct Professor of Cardiothoracic Surgery at Mount Sinai School of Medicine. Dr. Carpentier will present the Conclave Honored Lecture entitled “Revisiting the French Correction.” His landmark paper on mitral valve repair, “The French Correction”, was originally published in 1983 and he has been called “the father of modern mitral valve repair” by past AATS President Dr. Tyrone E. David.
Manuscripts from these and other selected presentations will be published in a supplement to The Journal of Thoracic and Cardiovascular Surgery this fall.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals. U.S. News & World Report consistently ranks The Mount Sinai Hospital among the nation’s best hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.
For more information, visit http://www.mountsinai.org/.